STABLE PHARMACEUTICAL COMPOSITIONS OF 5, 10 METHYLENETRAHYDROFOLATE
    1.
    发明申请
    STABLE PHARMACEUTICAL COMPOSITIONS OF 5, 10 METHYLENETRAHYDROFOLATE 审中-公开
    5,10甲基四氢叶酸酯的稳定的药物组合物

    公开(公告)号:US20090221594A1

    公开(公告)日:2009-09-03

    申请号:US12095458

    申请日:2006-11-30

    IPC分类号: A61K31/4985

    CPC分类号: A61K31/525 A61K9/19

    摘要: The invention provides a stable lyophilized composition of 5,10 methylenetetrahydrofolate suitable for use in the treatment of cancer and other therapies. The composition comprises 5,10-MTHF in combination with citric acid and ascorbic acid, with the ratio of citric acid to ascorbic acid from about 0.75:1 to about 2.25:1 by weight, and the ratio of total citric acid and ascorbic acid to 5,10-MTHF from about 1.4:1 to about 3.4:1 by weight. Prior to lyophilization, the solution is adjusted to an essentially neutral pH.

    摘要翻译: 本发明提供了适合用于治疗癌症和其它疗法的5,10亚甲基四氢叶酸的稳定的冻干组合物。 该组合物包含与柠檬酸和抗坏血酸组合的5,10-MTHF,柠檬酸与抗坏血酸的比例为约0.75:1至约2.25:1,总柠檬酸与抗坏血酸的比例与 5,10-MTHF为约1.4:1至约3.4:1重量比。 在冻干之前,将溶液调节至基本上中性的pH。

    Nucleic Acids Encoding Chimeric CD154 Polypeptides
    2.
    发明申请
    Nucleic Acids Encoding Chimeric CD154 Polypeptides 有权
    编码嵌合CD154多肽的核酸

    公开(公告)号:US20110177556A1

    公开(公告)日:2011-07-21

    申请号:US13074638

    申请日:2011-03-29

    IPC分类号: C12P21/02 C07K14/52 C07K16/24

    CPC分类号: C07K14/70575

    摘要: The present invention provides for an isolated polynucleotide sequence encoding a chimeric CD154, comprising a first nucleotide sequence encoding an extracellular subdomain of non-human CD154, preferably murine CD154, that replaces a cleavage site of human CD154, and a second nucleotide sequence encoding an extracellular subdomain of human CD154 that binds to a human CD154 receptor. The present invention also provides for the chimeric CD154 that is encoded by the above-described polynucleotide sequence, an expression vector and a genetic vector comprising the polynucleotide sequence, a host cell comprising the expression vector or the genetic vector, a process for producing the chimeric CD154, and methods for utilizing the expression vectors and genetic constructs containing the chimeric CD154 polynucleotide sequences.

    摘要翻译: 本发明提供了编码嵌合CD154的分离的多核苷酸序列,其包含编码非人CD154,优选小鼠CD154的细胞外亚结构域的第一核苷酸序列,其替代人CD154的切割位点,以及编码细胞外的第二核苷酸序列 结合人CD154受体的人CD154的亚结构域。 本发明还提供了由上述多核苷酸序列编码的嵌合CD154,表达载体和包含多核苷酸序列的遗传载体,包含表达载体或遗传载体的宿主细胞, CD154,以及用于使用含有嵌合CD154多核苷酸序列的表达载体和遗传构建体的方法。

    Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains
    3.
    发明授权
    Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains 有权
    编码包含TNFα,CD70和FAS配体结构域的多肽的嵌合核酸

    公开(公告)号:US07964712B2

    公开(公告)日:2011-06-21

    申请号:US12871807

    申请日:2010-08-30

    摘要: The present invention is directed to an isolated polynucleotide sequence encoding a chimeric TNFα, comprising a first nucleotide sequence encoding a domain or subdomain of a tumor necrosis factor ligand other than TNFα, wherein the encoded domain or subdomain replaces a cleavage site of native TNFα, and a second nucleotide sequence encoding a domain or subdomain of native TNFα that binds to a TNFα receptor. The encoded chimeric TNFα is significantly less susceptible to cleavage from the cellular surface and, as a result can increase the concentration of a ligand capable of binding to a TNFα receptor on the surface of a cell. The chimeric TNFα is therefore useful in methods for inducing apoptosis of a cell expressing a TNFα receptor, inducing activation of an immune system cell and treating neoplastic cells, by introducing into the cell of interest an isolated polynucleotide sequence encoding a chimeric TNFα that is expressed on the surface of the cell.

    摘要翻译: 本发明涉及编码嵌合TNFα的分离的多核苷酸序列,其包含编码除TNFα之外的肿瘤坏死因子配体的结构域或亚结构域的第一核苷酸序列,其中编码的结构域或亚结构域替代天然TNFα的切割位点,以及 编码结合TNFα受体的天然TNFα的结构域或亚结构域的第二核苷酸序列。 编码的嵌合TNFα对细胞表面的切割显着较不敏感,结果可以增加能够结合细胞表面的TNFα受体的配体的浓度。 因此,嵌合TNFα可用于诱导表达TNFα受体的细胞的凋亡,诱导免疫系统细胞的活化和治疗肿瘤细胞的方法,通过将编码嵌合TNFα的分离的多核苷酸序列引入感兴趣的细胞中,所述多核苷酸序列表达于 电池的表面。

    Nucleic acids encoding chimeric CD154 polypeptides
    4.
    发明授权
    Nucleic acids encoding chimeric CD154 polypeptides 有权
    编码嵌合CD154多肽的核酸

    公开(公告)号:US07928213B2

    公开(公告)日:2011-04-19

    申请号:US12389904

    申请日:2009-02-20

    CPC分类号: C07K14/70575

    摘要: The present invention provides for an isolated polynucleotide sequence encoding a chimeric CD154, comprising a first nucleotide sequence encoding an extracellular subdomain of non-human CD154, preferably murine CD154, that replaces a cleavage site of human CD154, and a second nucleotide sequence encoding an extracellular subdomain of human CD154 that binds to a human CD154 receptor. The present invention also provides for the chimeric CD154 that is encoded by the above-described polynucleotide sequence, an expression vector and a genetic vector comprising the polynucleotide sequence, a host cell comprising the expression vector or the genetic vector, a process for producing the chimeric CD154, and methods for utilizing the expression vectors and genetic constructs containing the chimeric CD154 polynucleotide sequences.

    摘要翻译: 本发明提供了编码嵌合CD154的分离的多核苷酸序列,其包含编码非人CD154,优选小鼠CD154的细胞外亚结构域的第一核苷酸序列,其替代人CD154的切割位点,以及编码细胞外的第二核苷酸序列 结合人CD154受体的人CD154的亚结构域。 本发明还提供了由上述多核苷酸序列编码的嵌合CD154,表达载体和包含多核苷酸序列的遗传载体,包含表达载体或遗传载体的宿主细胞, CD154,以及用于使用含有嵌合CD154多核苷酸序列的表达载体和遗传构建体的方法。

    NOVEL CHIMERIC TNF LIGANDS
    5.
    发明申请
    NOVEL CHIMERIC TNF LIGANDS 有权
    新的CHIMERIC TNF配体

    公开(公告)号:US20110008842A1

    公开(公告)日:2011-01-13

    申请号:US12871807

    申请日:2010-08-30

    摘要: The present invention is directed to an isolated polynucleotide sequence encoding a chimeric TNFα, comprising a first nucleotide sequence encoding a domain or subdomain of a tumor necrosis factor ligand other than TNFα, wherein the encoded domain or subdomain replaces a cleavage site of native TNFα, and a second nucleotide sequence encoding a domain or subdomain of native TNFα that binds to a TNFα receptor. The encoded chimeric TNFα is significantly less susceptible to cleavage from the cellular surface and, as a result can increase the concentration of a ligand capable of binding to a TNFα receptor on the surface of a cell. The chimeric TNFα is therefore useful in methods for inducing apoptosis of a cell expressing a TNFα receptor, inducing activation of an immune system cell and treating neoplastic cells, by introducing into the cell of interest an isolated polynucleotide sequence encoding a chimeric TNFα that is expressed on the surface of the cell.

    摘要翻译: 本发明涉及编码嵌合TNFα的分离的多核苷酸序列,其包含编码除TNFα之外的肿瘤坏死因子配体的结构域或亚结构域的第一核苷酸序列,其中编码的结构域或亚结构域替代天然TNFα的切割位点,以及 编码结合TNFα受体的天然TNFα的结构域或亚结构域的第二核苷酸序列。 编码的嵌合TNFα对细胞表面的切割显着较不敏感,结果可以增加能够结合细胞表面的TNFα受体的配体的浓度。 因此,嵌合TNFα可用于诱导表达TNFα受体的细胞的凋亡,诱导免疫系统细胞的活化和治疗肿瘤细胞的方法,通过将编码嵌合TNFα的分离的多核苷酸序列引入感兴趣的细胞中,所述多核苷酸序列表达于 电池的表面。

    Chimeric CD154 polypeptides
    6.
    发明授权
    Chimeric CD154 polypeptides 有权
    嵌合CD154多肽

    公开(公告)号:US08138310B2

    公开(公告)日:2012-03-20

    申请号:US13074638

    申请日:2011-03-29

    IPC分类号: C07K14/705

    CPC分类号: C07K14/70575

    摘要: The present invention provides for an isolated polynucleotide sequence encoding a chimeric CD154, comprising a first nucleotide sequence encoding an extracellular subdomain of non-human CD154, preferably murine CD154, that replaces a cleavage site of human CD154, and a second nucleotide sequence encoding an extracellular subdomain of human CD154 that binds to a human CD154 receptor. The present invention also provides for the chimeric CD154 that is encoded by the above-described polynucleotide sequence, an expression vector and a genetic vector comprising the polynucleotide sequence, a host cell comprising the expression vector or the genetic vector, a process for producing the chimeric CD154, and methods for utilizing the expression vectors and genetic constructs containing the chimeric CD154 polynucleotide sequences.

    摘要翻译: 本发明提供了编码嵌合CD154的分离的多核苷酸序列,其包含编码非人CD154,优选小鼠CD154的细胞外亚结构域的第一核苷酸序列,其替代人CD154的切割位点,以及编码细胞外的第二核苷酸序列 结合人CD154受体的人CD154的亚结构域。 本发明还提供了由上述多核苷酸序列编码的嵌合CD154,表达载体和包含多核苷酸序列的遗传载体,包含表达载体或遗传载体的宿主细胞, CD154,以及用于使用含有嵌合CD154多核苷酸序列的表达载体和遗传构建体的方法。

    Nucleic acids encoding chimeric CD154 polypeptides
    7.
    发明授权
    Nucleic acids encoding chimeric CD154 polypeptides 有权
    编码嵌合CD154多肽的核酸

    公开(公告)号:US07495090B2

    公开(公告)日:2009-02-24

    申请号:US10154759

    申请日:2002-05-23

    CPC分类号: C07K14/70575

    摘要: The present invention provides for an isolated polynucleotide sequence encoding a chimeric CD154, comprising a first nucleotide sequence encoding an extracellular subdomain of non-human CD154, preferably murine CD154, that replaces a cleavage site of human CD154, and a second nucleotide sequence encoding an extracellular subdomain of human CD154 that binds to a human CD154 receptor. The present invention also provides for the chimeric CD154 that is encoded by the above-described polynucleotide sequence, an expression vector and a genetic vector comprising the polynucleotide sequence, a host cell comprising the expression vector or the genetic vector, a process for producing the chimeric CD154, and methods for utilizing the expression vectors and genetic constructs containing the chimeric CD154 polynucleotide sequences.

    摘要翻译: 本发明提供了编码嵌合CD154的分离的多核苷酸序列,其包含编码非人CD154,优选小鼠CD154的细胞外亚结构域的第一核苷酸序列,其替代人CD154的切割位点,以及编码细胞外的第二核苷酸序列 结合人CD154受体的人CD154的亚结构域。 本发明还提供了由上述多核苷酸序列编码的嵌合CD154,表达载体和包含多核苷酸序列的遗传载体,包含表达载体或遗传载体的宿主细胞, CD154,以及用于使用含有嵌合CD154多核苷酸序列的表达载体和遗传构建体的方法。

    Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
    8.
    发明申请
    Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain 审中-公开
    编码具有CD154结构域的TNF-α配体多肽的核酸分子

    公开(公告)号:US20120116052A1

    公开(公告)日:2012-05-10

    申请号:US13106675

    申请日:2011-05-12

    IPC分类号: C07K19/00 C12P21/00

    摘要: The present invention is directed to an isolated polynucleotide sequence encoding a chimeric TNFα, comprising a first nucleotide sequence encoding a domain or subdomain of a tumor necrosis factor ligand other than TNFα, wherein the encoded domain or subdomain replaces a cleavage site of native TNFα, and a second nucleotide sequence encoding a domain or subdomain of native TNFα that binds to a TNFα receptor. The encoded chimeric TNFα is significantly less susceptible to cleavage from the cellular surface and, as a result can increase the concentration of a ligand capable of binding to a TNFα receptor on the surface of a cell. The chimeric TNFα is therefore useful in methods for inducing apoptosis of a cell expressing a TNFα receptor, inducing activation of an immune system cell and treating neoplastic cells, by introducing into the cell of interest an isolated polynucleotide sequence encoding a chimeric TNFα that is expressed on the surface of the cell.

    摘要翻译: 本发明涉及编码嵌合TNFα的分离的多核苷酸序列,其包含编码除TNFα之外的肿瘤坏死因子配体的结构域或亚结构域的第一核苷酸序列,其中编码的结构域或亚结构域替代天然TNFα的切割位点,以及 编码结合TNFα受体的天然TNFα的结构域或亚结构域的第二核苷酸序列。 编码的嵌合TNFα对细胞表面的切割显着较不敏感,结果可以增加能够结合细胞表面的TNFα受体的配体的浓度。 因此,嵌合TNFα可用于诱导表达TNFα受体的细胞的凋亡,诱导免疫系统细胞的活化和治疗肿瘤细胞的方法,通过将编码嵌合TNFα的分离的多核苷酸序列引入感兴趣的细胞中,所述多核苷酸序列表达于 电池的表面。

    Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
    9.
    发明授权
    Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain 有权
    编码具有CD154结构域的TNF-α配体多肽的核酸分子

    公开(公告)号:US07786282B2

    公开(公告)日:2010-08-31

    申请号:US10006305

    申请日:2001-12-06

    摘要: The present invention is directed to an isolated polynucleotide sequence encoding a chimeric TNFα and chimeric TNFα polypeptides. The former have a first nucleotide sequence encoding a domain or subdomain of a tumor necrosis factor ligand other than TNFα, wherein the encoded domain or subdomain lacks a cleavage site, and a second nucleotide sequence encoding a domain or subdomain of native TNFα that binds to a TNFα receptor. The encoded chimeric TNFα is significantly less susceptible to cleavage from the cellular surface and, as a result can increase the concentration of a ligand capable of binding to a TNFα receptor on the surface of a cell. The chimeric TNFα is therefore useful in methods for inducing apoptosis of a cell expressing a TNFα receptor, inducing activation of an immune system cell and treating neoplastic cells, by introducing into the cell of interest an isolated polynucleotide sequence encoding a chimeric TNFα that is expressed on the surface of the cell.

    摘要翻译: 本发明涉及编码嵌合TNFα和嵌合TNFα多肽的分离的多核苷酸序列。 前者具有编码除TNFα之外的肿瘤坏死因子配体的结构域或亚结构域的第一核苷酸序列,其中编码的结构域或亚结构域缺乏切割位点,以及编码天然TNFα结构域或亚结构域的第二核苷酸序列 TNFα受体。 编码的嵌合TNFα对细胞表面的切割显着较不敏感,结果可以增加能够结合细胞表面的TNFα受体的配体的浓度。 因此,嵌合TNFα可用于诱导表达TNFα受体的细胞的凋亡,诱导免疫系统细胞的活化和治疗肿瘤细胞的方法,通过将编码嵌合TNFα的分离的多核苷酸序列引入感兴趣的细胞中,所述多核苷酸序列表达于 电池的表面。